grey market peptides retatrutide review InSight+ Unapproved peptides seized as TGA

Possible Side Effects and When to Seek Medical Advice Retatrutide commonly causes gastrointestinal effects such as nausea, vomiting, and diarrhoea, especially during dose escalation

93% lost 10% or more

Sofwave was FDA-approved five years ago as a non-invasive way to lift and smooth skin

The dysesthesia signal is concerning and needs more investigation

The bottom line Nausea is a common side effect when taking a GLP-1 because of the way the medication slows down digestion

The relationship between GLP-1 receptor agonists and generalized skin sensitivity remains unclear, as there is no official established link between these medications and widespread sensitive skin as a direct pharmacological effect